Cargando…
Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review
INTRODUCTION: In this study, we evaluated the use and the contribution of radiopharmaceuticals to the field of lung neoplasms imaging using positron emission tomography/computed tomography. METHODS: We conducted review of the current literature at PubMed/MEDLINE until February 2020. The search langu...
Autores principales: | Theodoropoulos, Athanasios S, Gkiozos, Ioannis, Kontopyrgias, Georgios, Charpidou, Adrianni, Kotteas, Elias, Kyrgias, George, Tolia, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534078/ https://www.ncbi.nlm.nih.gov/pubmed/33062275 http://dx.doi.org/10.1177/2050312120961594 |
Ejemplares similares
-
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013) -
Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors
por: Jung, Ji-hoon, et al.
Publicado: (2018) -
Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019) -
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022) -
Quality control of positron emission tomography radiopharmaceuticals: An institutional experience
por: Shukla, Jaya, et al.
Publicado: (2013)